This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kevin Francis Deboyace: Innovator in Pharmaceutical Development
Introduction
Kevin Francis Deboyace is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific health conditions.
Latest Patents
Kevin holds a patent for BCKDK inhibitors and/or degraders. This patent describes compounds of Formula I, which are defined within the documentation. These compounds are recognized for their potential use as branched-chain alpha keto acid dehydrogenase kinase inhibitors and/or degraders. They are formulated to treat various health issues, including diabetes, kidney disease, NASH, and heart failure.
Career Highlights
Kevin is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work focuses on innovative solutions that address critical health challenges. His expertise in the field has positioned him as a valuable asset to his team and the industry.
Collaborations
Kevin collaborates with talented professionals, including Leanne Marie Buzon and Kimberly O'Keefe Cameron. These partnerships enhance the research and development efforts within his projects.
Conclusion
Kevin Francis Deboyace exemplifies innovation in the pharmaceutical industry through his patent and contributions at Pfizer Corporation. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile